Nu Skin Enterprises director adds shares via dividend reinvestment

Nu Skin Enterprises director reports small share increase through plan dividend A Nu Skin Enterprises, Inc. director filed a Form 4 reporting the acquisition of 10 shares of Class A common stock on 12/10/2025 at a price of $10.35 per share.

Rhea-AI Filing Summary

Nu Skin Enterprises director reports small share increase through plan dividend

A Nu Skin Enterprises, Inc. director filed a Form 4 reporting the acquisition of 10 shares of Class A common stock on 12/10/2025 at a price of $10.35 per share. The filing states these shares were acquired through dividend reinvestment under the company’s Deferred Compensation Plan in accordance with the plan’s terms. Following this transaction, the director beneficially owns 42,979 shares, held directly. This is a routine insider ownership update showing plan-based reinvestment rather than an open-market trade.

Insider Trade Summary

Grant/Award: 10 shares

Grant/Award 1 txn

Insider WOODBURY EDWINA D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	10	$10.35	$103.50

Holdings After Transaction: Class A Common Stock — 42,979 shares (Direct)

Footnotes (1)

1. F1. These shares were acquired through a dividend reinvestment under the Company's Deferred Compensation Plan in accordance with the Plan's terms.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Nu Skin Enterprises (NUS) report on this Form 4?

The Form 4 reports that a Nu Skin Enterprises, Inc. director acquired 10 shares of Class A common stock on 12/10/2025 through dividend reinvestment under the company’s Deferred Compensation Plan.

At what price were the Nu Skin Enterprises (NUS) shares acquired in this transaction?

The 10 Class A common shares were reported as acquired at a price of $10.35 per share.

How many Nu Skin Enterprises (NUS) shares does the reporting person own after this transaction?

After the reported dividend reinvestment, the director is shown as beneficially owning 42,979 shares of Nu Skin Enterprises Class A common stock, held directly.

What was the method of acquisition for these Nu Skin Enterprises (NUS) shares?

The filing explains that the 10 shares were acquired through dividend reinvestment under Nu Skin Enterprises’ Deferred Compensation Plan, in line with that plan’s terms.

What is the relationship of the reporting person to Nu Skin Enterprises (NUS)?

The reporting person is identified as a Director of Nu Skin Enterprises, Inc., and the Form 4 is filed as a Form filed by One Reporting Person.

Does this Nu Skin Enterprises (NUS) Form 4 involve derivative securities?

The provided Form 4 excerpt shows data in Table I only, covering non-derivative Class A common stock, with no derivative securities transactions listed in Table II.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/11/2025 - 04:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WOODBURY EDWINA D

(Last) (First) (Middle)

C/O NU SKIN ENTERPRISES, INC.

75 W CENTER STREET

(Street)

PROVO UT 84601

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/10/2025		A		10(1)	A	$10.35	42,979	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were acquired through a dividend reinvestment under the Company's Deferred Compensation Plan in accordance with the Plan's terms.

	/s/ Gregory Belliston as Attorney-in-Fact for Edwina D. Woodbury	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.